{"id":"W4361988864","doi":"10.1177/17588359231156382","title":"A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Medical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"FP7 Health; Pharmacyclics; Sanofi Genzyme; Genentech; Daiichi Sankyo Europe; National Cancer Institute; Servier; AstraZeneca; Institut National Du Cancer; Canadian Cancer Society; Foundation Medicine; Fondation ARC pour la Recherche sur le Cancer; Seagen; Puma Biotechnology; Actuate Therapeutics; Symphogen; Pfizer; Incyte; Grifols; EQRx; BeiGene; European Commission; Sanofi; Halozyme; Chugai Pharmaceutical; Israel Science Foundation; Ipsen; Array BioPharma; Bristol-Myers Squibb; Eli Lilly and Company; American Society of Clinical Oncology; Instituto de Salud Carlos III; Amgen; Novartis Pharmaceuticals Corporation; Les Laboratories Pierre Fabre","keywords":"Medicine; Oncology; Clinical trial; Internal medicine; Immunotherapy; Metastasis; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004589919,0.0008649275,0.001192407,0.001139376,0.0003943861,0.002289472,0.001065976,0.001333234,0.006038766],"category_scores_gemma":[0.006953433,0.0007982338,0.001457192,0.0009148369,0.001189902,0.001953143,0.001006896,0.001867158,0.001359732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001805961,"about_ca_system_score_gemma":0.0023281,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001097355,"about_ca_topic_score_gemma":0.00151127,"domain_scores_codex":[0.9986429,0.0008082493,0.00006812815,0.0002219942,0.0001990889,0.00005974074],"domain_scores_gemma":[0.9966726,0.002327893,0.0003432009,0.0003627666,0.0001803939,0.00011303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.00122448,0.0005827324,0.01397708,0.0021122,0.0006701905,0.000399536,0.0003321763,0.3974912,0.1599341,0.194812,0.01196851,0.2164958],"study_design_scores_gemma":[0.0002617976,0.0008974185,0.003920533,0.0002690415,0.0003683404,0.000314031,0.0001692596,0.6069492,0.02102471,0.3036877,0.06202033,0.0001177985],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.01828083,0.002001259,0.9645148,0.005104438,0.0003050971,0.0006100325,0.00211892,0.001608153,0.005456403],"genre_scores_gemma":[0.1875737,0.004629669,0.7972434,0.00234644,0.000326741,0.002254384,0.002073346,0.0002528721,0.003299464],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.006038766,"threshold_uncertainty_score":0.02427411,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1778064220423873,"score_gpt":0.5108081939300281,"score_spread":0.3330017718876408,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}